77 related articles for article (PubMed ID: 14973506)
1. Erythroleukaemia and RAEB-t: a same disease?
Park S; Picard F; Guesnu M; Maloum K; Leblond V; Dreyfus F
Leukemia; 2004 Apr; 18(4):888-90. PubMed ID: 14973506
[No Abstract] [Full Text] [Related]
2. Erythroleukemia: a need for a new definition.
Park S; Picard F; Dreyfus F
Leukemia; 2002 Aug; 16(8):1399-401. PubMed ID: 12145675
[TBL] [Abstract][Full Text] [Related]
3. Refractory anaemia with excess of blasts in transformation re-evaluated with the WHO criteria: identification of subgroups with different survival.
Breccia M; Latagliata R; Carmosino I; Gentilini F; D'Elia GM; Levi A; Natalino F; Frustaci A; De Cuia MR; Alimena G
Acta Haematol; 2007; 117(4):221-5. PubMed ID: 17259693
[TBL] [Abstract][Full Text] [Related]
4. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
Estey EH; Kantarjian HM; O'Brien S; Kornblau S; Andreeff M; Beran M; Pierce S; Keating M
Cytokines Mol Ther; 1995 Mar; 1(1):21-8. PubMed ID: 9384660
[TBL] [Abstract][Full Text] [Related]
5. Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals.
Germing U; Strupp C; Kuendgen A; Aivado M; Giagounidis A; Hildebrandt B; Aul C; Haas R; Gattermann N
Br J Haematol; 2006 Jan; 132(2):162-7. PubMed ID: 16398650
[TBL] [Abstract][Full Text] [Related]
6. Analysis of prognostic factors in patients with refractory anemia with excess of blasts (RAEB) reclassified according to WHO proposal.
Breccia M; Latagliata R; Cannella L; Carmosino I; De Cuia R; Frustaci A; Stefanizzi C; Santopietro M; Alimena G
Leuk Res; 2009 Mar; 33(3):391-4. PubMed ID: 18676015
[TBL] [Abstract][Full Text] [Related]
7. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB).
Omine M; Yamauchi H
Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):800-10. PubMed ID: 2618556
[TBL] [Abstract][Full Text] [Related]
8. [Refractory anemia with excess of blasts (RAEB) and erythroleukemia (M6) in two brothers].
Takahira H; Ogo J; Nishimura J; Ibayashi H; Umemura T; Hirata J; Toyomura M; Asayama R
Rinsho Ketsueki; 1988 Mar; 29(3):395-401. PubMed ID: 3165146
[No Abstract] [Full Text] [Related]
9. RAEB-t in young adults--a rare entity.
Tilak V; Akhtar S; Alam K
Indian J Pathol Microbiol; 2003 Apr; 46(2):228-30. PubMed ID: 15022920
[TBL] [Abstract][Full Text] [Related]
10. [Cytogenetic studies in myelodysplasias].
Grebe G; Legues ME; Veloso M; Morizon G; Chuecas F; Lira P
Rev Med Chil; 1991 Dec; 119(12):1396-402. PubMed ID: 9723096
[TBL] [Abstract][Full Text] [Related]
11. [Successful treatment of refractory anemia with excess of blasts in transformation with cytarabine ocfosfate].
Takeuchi M; Kojima K; Takaba S; Isokawa M; Tanimizu M; Kimura F; Ohmoto E; Harada M
Gan To Kagaku Ryoho; 1995 Jan; 22(1):141-4. PubMed ID: 7826071
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
[TBL] [Abstract][Full Text] [Related]
13. [Refractory anemia showing excess of blasts (BAEB) that transformed into acute myelogenous leukemia (AML-M2) with a t (?8;20) chromosomal abnormality].
Maekawa T; Fujii H; Shizumi Y; Ebisui S; Horishi M; Suyama Y; Miyoshi M; Horiike S
Gan No Rinsho; 1988 Dec; 34(15):2109-13. PubMed ID: 3230641
[TBL] [Abstract][Full Text] [Related]
14. [Refractory anemia with excess of blasts (RAEB)].
Yoshida Y
Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):195-7. PubMed ID: 9851119
[No Abstract] [Full Text] [Related]
15. [The appearance of Sweet's syndrome during the transition from a myelodysplastic syndrome to erythroleukemia].
Grüne S; Panizzon R; Egli F; Siegenthaler W; Greminger P
Dtsch Med Wochenschr; 1996 Jul; 121(30):939-42. PubMed ID: 8765702
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the KIT gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia.
Lorenzo F; Nishii K; Monma F; Kuwagata S; Usui E; Shiku H
Leuk Res; 2006 Oct; 30(10):1235-9. PubMed ID: 16533529
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
Ghaddar HM; Stass SA; Pierce S; Estey EH
Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
[TBL] [Abstract][Full Text] [Related]
18. Treatment with low-dose cytosine arabinoside followed by administration of macrophage colony-stimulating factor prolongs the survival of patients with RAEB, RAEB-T, or leukemic phase myelodysplastic syndrome: a pilot study.
Fukuhara T; Miyake T; Maekawa I; Kurosawa M; Suzuki S; Noto S; Mori A; Chiba K; Toyoshima T; Hirano T; Morioka M; Tsutsumi Y; Okabe M; Kakinoki Y
Int J Hematol; 2000 Jun; 71(4):366-71. PubMed ID: 10905057
[TBL] [Abstract][Full Text] [Related]
19. Atypical Sweet's syndrome in a neutropenic patient with acute myeloid leukemia, secondary to a RAEB-T, simulating thrombophlebitis.
Equitani F; Mele L; Rutella S; Belli P; Paciaroni K; Piscitelli R; Pagano L
Panminerva Med; 1999 Sep; 41(3):261-3. PubMed ID: 10568127
[TBL] [Abstract][Full Text] [Related]
20. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia.
Huh YO; Jilani I; Estey E; Giles F; Kantarjian H; Freireich E; Albitar M
Leukemia; 2002 Nov; 16(11):2249-52. PubMed ID: 12399969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
